LBO — MERCY MEDICAL CENTER
IRR: 18.9% | MOIC: 2.37x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.9%
IRR
2.37x
MOIC
$289.9M
Entry EV
$476.7M
Exit EV
$149.2M
Equity Invested
Sources & Uses
S&UTotal · $289.9M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $112.6M | 38.8% | |
| Sub Debt | $28.1M | 9.7% | |
| Equity | $149.2M | 51.5% | |
| Enterprise Value | $281.5M | 97.1% | |
| Transaction Fees | $8.4M | 2.9% | |
| Total Uses | $289.9M | 100.0% |
Interpretation
INTAt 2.37x MOIC and 18.9% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $45.4M |
| Exit Ev | $476.7M |
| Net Debt At Exit | $122.8M |
| Equity At Exit | $354.0M |
| Equity Invested | $149.2M |
| Total Value Created | $204.8M |
| Value From Growth | $181.2M |
| Value From Multiple | $14.1M |
| Value From Deleveraging | $18.0M |